MJ_0883

MJ_0883

Your search terms and filters produced no results.

Please use the Biomolecules search tool above to find what you're looking for.

Suggested Products

  • VECTASHIELD® Mounting Media

    VECTASHIELD® Mounting Media

    VECTASHIELD® Mounting Media are unsurpassed in preventing photobleaching. These ready-to-use antifade mounting media are stored at 4 ºC, available in non-hardening and hardening versions, and with and without counterstains. Features: Inhibits photobleaching of fluorescent dyes and fluorescent proteins Ideal refractive index (1.45) Ready-to-use - from the refrigerator to the benchtop No warming necessary Can be stored without sealing for long term analysis Non-hardening formulation ...
  • TransScript® One-Step gDNA Removal and cDNA Synthesis SuperMix

    TransScript® One-Step gDNA Removal and cDNA Synthesis SuperMix

    Unique genomic DNA remover is combined with TransScript® First-Strand cDNA Synthesis SuperMix to achieve simultaneous genomic DNA removal and cDNA synthesis. After cDNA synthesis, gDNA remover and reverse transcriptase are inactivated by heating at 85℃ for 5 seconds Features Simultaneous genomic DNA removal and cDNA synthesis in one tube to minimize RNA contamination. The product obtained from 15 minutes reaction is used for qPCR; the product obtained from 30 minutes reaction is ...
  • <<
  • >>

Recent Product Review

  • Excellent Tempus™ Spin RNA Isolation Kit

    Excellent Tempus™ Spin RNA Isolation Kit

    Reliable and easy-to-use kit that provides consistent, high quality RNA from peripheral blood.
  • BIO CEO & Investor Conference

    BIO CEO & Investor Conference

    Returning for its 22nd year, the BIO CEO & Investor Conference will take place February 10-11 in New York. As one of the only independent East-Coast partnering events dedicated to showcasing the hottest clinical developments that are ready for their next stage of development, the BIO CEO & Investor Conference will attract 1,200+ attendees, including more than 650 early-stage and institutional investors focused on accelerating the progress of both therapeutic technologies and molecular diagnostics into commercialization and helping patients.

Guided Browse

Browse by Molecule Name